η-Secretase processing of APP inhibits neuronal activity in the hippocampus
暂无分享,去创建一个
Jochen Herms | Lars Lannfelt | Frederick J. Livesey | Felix Meissner | Vilmantas Giedraitis | Dietmar R. Thal | Saak V. Ovsepian | Arthur Konnerth | Michael T. Heneka | Hélène Marie | Christian Haass | Michael Willem | A. Konnerth | E. Kremmer | F. J. Livesey | L. Lannfelt | Daniel Hornburg | F. Meissner | M. Heneka | V. Giedraitis | S. Ovsepian | H. Marie | J. Herms | C. Haass | D. Thal | U. Müller | B. Nuscher | M. A. Busche | M. Willem | Elisabeth Kremmer | L. Evans | Ulrike Müller | Veronika Müller | Marc Aurel Busche | S. Tahirovic | Brigitte Nuscher | Daniel Hornburg | Magda Chafai | C. Giudici | Sabina Tahirovic | Scherazad Kootar | Lewis D. B. Evans | Steven Moore | Anna Daria | Heike Hampel | Camilla Giudici | Andrea Wenninger-Weinzierl | A. Wenninger-Weinzierl | V. Müller | S. Kootar | H. Hampel | S. Moore | Magda Chafai | A. Daria
[1] B. Winblad,et al. Amyloid β-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation , 1995, Neuroscience Letters.
[2] G. Westmeyer,et al. Dimerization of β-Site β-Amyloid Precursor Protein-cleaving Enzyme* , 2004, Journal of Biological Chemistry.
[3] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[4] C. Overall,et al. Metalloprotease Meprin β Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo* , 2011, The Journal of Biological Chemistry.
[5] M. Mann,et al. Higher-energy C-trap dissociation for peptide modification analysis , 2007, Nature Methods.
[6] J. Teller,et al. Diethylamine extraction of proteins and peptides isolated with a mono-phasic solution of phenol and guanidine isothiocyanate. , 2006, Journal of biochemical and biophysical methods.
[7] Marc Tessier-Lavigne,et al. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases , 2009, Nature.
[8] Ole A. Andreassen,et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.
[9] M. Mann,et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.
[10] K. Blennow,et al. Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[11] Bert Sakmann,et al. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease , 2012, Proceedings of the National Academy of Sciences.
[12] Kristopher L. Nazor,et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.
[13] Junmin Peng,et al. Proteomic Characterization of Postmortem Amyloid Plaques Isolated by Laser Capture Microdissection*[boxs] , 2004, Journal of Biological Chemistry.
[14] Hiroyuki Arai,et al. Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain‐specific MMP highly expressed in cerebellum , 2001, The European journal of neuroscience.
[15] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[16] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[17] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[18] L. Ozmen,et al. Combined Treatment with a BACE Inhibitor and Anti-Aβ Antibody Gantenerumab Enhances Amyloid Reduction in APPLondon Mice , 2014, The Journal of Neuroscience.
[19] C. Stosiek,et al. In vivo two-photon calcium imaging of neuronal networks , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] H. Cai,et al. BACE1 is the major β-secretase for generation of Aβ peptides by neurons , 2001, Nature Neuroscience.
[21] S. Kaech,et al. Culturing hippocampal neurons , 2006, Nature Protocols.
[22] R. Cappai,et al. Identification of a novel amyloid precursor protein processing pathway that generates secreted N‐terminal fragments , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] Shaomin Li,et al. Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity , 2014, Biochemistry.
[24] Munirah Ahmad,et al. Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases. , 2006, Journal of biochemistry.
[25] Hartwig Wolburg,et al. Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology , 2006, EMBO reports.
[26] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[27] S. Squazzo,et al. Aggregation of Secreted Amyloid -Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture (*) , 1995, The Journal of Biological Chemistry.
[28] Thomas Rülicke,et al. Behavioral and anatomical deficits in mice homozygous for a modified β-amyloid precursor protein gene , 1994, Cell.
[29] A. Cattaneo,et al. Transgenic Mice with Chronic NGF Deprivation and Alzheimer's Disease-Like Pathology Display Hippocampal Region-Specific Impairments in Short- and Long-Term Plasticities , 2010, The Journal of Neuroscience.
[30] R. Bateman,et al. CNS Amyloid-β, Soluble APP-α and -β Kinetics during BACE Inhibition , 2014, The Journal of Neuroscience.
[31] S. Younkin,et al. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. , 1992, Science.
[32] Arthur Konnerth,et al. Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease , 2008, Science.
[33] K. Miyazaki,et al. Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A. , 2003, Biochemistry.
[34] Bernardo L Sabatini,et al. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.
[35] D. Selkoe,et al. Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers , 2006, The Journal of physiology.
[36] C. Haass. Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation , 2004 .
[37] Peter Kirwan,et al. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses , 2012, Nature Neuroscience.
[38] U. Schepers,et al. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons , 2012, The EMBO journal.
[39] Veerle Baekelandt,et al. Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.
[40] D. Selkoe,et al. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.
[41] C. López-Otín,et al. Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation , 2009, Proceedings of the National Academy of Sciences.
[42] Matthias Mann,et al. The Q Exactive HF, a Benchtop Mass Spectrometer with a Pre-filter, High-performance Quadrupole and an Ultra-high-field Orbitrap Analyzer* , 2014, Molecular & Cellular Proteomics.
[43] R. W. Rauser,et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Selkoe,et al. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway , 1995, Nature Medicine.
[45] M. Mann,et al. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.
[46] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[47] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[48] J. Hardy,et al. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family , 1994, Neuroscience Letters.
[49] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[50] F. J. Livesey,et al. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks , 2012, Nature Protocols.
[51] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[52] D. Selkoe,et al. beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. , 1993, The Journal of biological chemistry.
[53] B. de Strooper,et al. The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo* , 2012, The Journal of Biological Chemistry.